NCT05931549 Cortisol, Hippocampus, and Insula in Anorexia Nervosa.
| NCT ID | NCT05931549 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Odense University Hospital |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-09-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
EXCENTRICC is a platform for scientific collaboration between different disciplines, all working on a common theme: adrenocortical hormones. In this EXCENTRICC sub-study, associations are studied between cortisol levels and depression, anxiety, disease severity and hippocampal and insula volume in the brain in anorexia nervosa.
Eligibility Criteria
Inclusion Criteria: 1. Women who fulfill the criteria for AN according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), version 5 (APA, 2013). 2. BMI \< 16. Exclusion Criteria: 1. Current treatment with glucocorticoids. 2. Current use of oral contraceptives. 3. Unstable acute somatic comorbidity, e.g., infection. 4. Any kind of metal prostheses or -implants.
Contact & Investigator
René K Støving, PhD
PRINCIPAL INVESTIGATOR
Odense University Hospital
Frequently Asked Questions
Who can join the NCT05931549 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05931549 currently recruiting?
Yes, NCT05931549 is actively recruiting participants. Contact the research team at rene.stoeving@rsyd.dk for enrollment information.
Where is the NCT05931549 trial being conducted?
This trial is being conducted at Odense, Denmark.
Who is sponsoring the NCT05931549 clinical trial?
NCT05931549 is sponsored by Odense University Hospital. The principal investigator is René K Støving, PhD at Odense University Hospital. The trial plans to enroll 80 participants.